Injective
Why Injective is up 4.4% today
Analysis
Injective (INJ) rose 4.4% over the past 24 hours as ETF-related headlines boosted sentiment, including reporting that CEO Eric Chen expects US INJ ETFs to arrive sooner than 2027. INJ also got a catalyst from news that Injective launched the “Trench Treasury” as Canary filed an SEC ETF, reinforcing the market’s focus on potential regulated investment access and ecosystem developments.
Contributing Factors (2)
Injective launches Trench Treasury as Canary files SEC ETF – Details
Injective ecosystem saw two major developments; Injective Foundation launched the Trench Treasury while Canary Capital filed with the SEC for Staked INJ ETF.
Injective CEO Eric Chen expects US INJ ETFs to launch sooner than 2027
There are currently two ETF applications tied to INJ — the 21Shares Injective ETF and the Canary Staked INJ ETF.
Move Details
Explanation Confidence
High confidence in the explanation based on source reliability and timing.